KALV — KalVista Pharmaceuticals, Inc. stock price, charts and financials

QT68KalVista Pharmaceuticals, Inc.

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
27.00
+0.00%
KALVQT68KalVista Pharmaceuticals, Inc.·NASDAQ
27.00+0.00%

Latest SEC Filings

Form category
Filing DateFormDescriptionFilingDocument
Jun 22, 202615-12G15-12G
Jun 16, 2026EFFECTNotice of effectiveness
Jun 11, 20264Statement of changes in beneficial ownership
Jun 11, 20264Statement of changes in beneficial ownership
Jun 11, 2026S-8 POSS-8 POS
Jun 11, 20264Statement of changes in beneficial ownership
Jun 11, 2026S-8 POSS-8 POS
Jun 11, 2026S-8 POSS-8 POS
Jun 11, 2026POS AMPost-effective amendment
Jun 11, 20264Statement of changes in beneficial ownership
Jun 11, 2026S-8 POSS-8 POS
Jun 11, 20264Statement of changes in beneficial ownership
Jun 11, 20264Statement of changes in beneficial ownership
Jun 11, 2026SC 14D9/ASC 14D9/A
Jun 11, 2026S-8 POSS-8 POS
Jun 11, 20268-KCurrent report
Jun 11, 20264Statement of changes in beneficial ownership
Jun 11, 2026S-8 POSS-8 POS
Jun 11, 20264Statement of changes in beneficial ownership
Jun 11, 2026S-8 POSS-8 POS
Jun 11, 2026S-8 POSS-8 POS
Jun 11, 2026S-8 POSS-8 POS
Jun 11, 2026S-8 POSS-8 POS
Jun 11, 2026S-8 POSS-8 POS
Jun 11, 2026S-8 POSS-8 POS